Skip to content
October 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Treatment Innovations
  • Medical Research and Clinical Trials
  • Genomics and Precision Medicine
  • Survivorship and Post-Treatment
  • Integrative Oncology and Holistic Care
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Breast Cancer Legislation and Policy
  • Breast Cancer Surgery and Reconstruction
Breaking News
unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3 A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed pioneering-the-future-of-medicine-three-broad-institute-scientists-secure-prestigious-nih-high-risk-high-reward-grants-1 Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants

Main News

unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026
pioneering-the-future-of-medicine-three-broad-institute-scientists-secure-prestigious-nih-high-risk-high-reward-grants-1
  • Genomics and Precision Medicine

Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants

Evan Lee Salim October 7, 2026
  • Recommended
  • Popular
  • Archive
  • Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
    • Medical Research and Clinical Trials

    Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

    Sagoh October 7, 2026
  • ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
    • Medical Research and Clinical Trials

    ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

    Pevita Pearce October 7, 2026
  • A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
    • Genomics and Precision Medicine

    A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

    Rifan Muazin October 7, 2026
  • Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
    • Genomics and Precision Medicine

    Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

    Suro Senen October 7, 2026
  • The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research the-digital-renaissance-of-pathology-mining-archives-to-redefine-preclinical-research-2
    • Chemotherapy and Targeted Therapy

    The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

    Siti Muinah October 7, 2026
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
    • Medical Research and Clinical Trials

    Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

    Sagoh October 7, 2026
  • ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
    • Medical Research and Clinical Trials

    ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

    Pevita Pearce October 7, 2026
  • A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
    • Genomics and Precision Medicine

    A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

    Rifan Muazin October 7, 2026
  • Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
    • Genomics and Precision Medicine

    Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

    Suro Senen October 7, 2026

Featured News

unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026

General

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026

Opinion

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026

More

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026
Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
NORMAN, OKLAHOMA – In a significant breakthrough that could redefine future cancer treatments, new research from the...
Read More Read more about Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth
ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
The oncology landscape for non-small cell lung cancer (NSCLC) with specific EGFR mutations has taken a significant...
Read More Read more about ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape
A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
Read More Read more about A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation
Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026
Age-related hearing loss, often dismissed as an inevitable consequence of the aging process, is emerging as a...
Read More Read more about Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed
Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants pioneering-the-future-of-medicine-three-broad-institute-scientists-secure-prestigious-nih-high-risk-high-reward-grants-1
  • Genomics and Precision Medicine

Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants

Evan Lee Salim October 7, 2026
In a significant validation of bold, unconventional scientific inquiry, the National Institutes of Health (NIH) has recognized...
Read More Read more about Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants
Beyond the Parade: The Resilience and Legacy of Richard Goldman’s Lifelong Commitment to Community beyond-the-parade-the-resilience-and-legacy-of-richard-goldmans-lifelong-commitment-to-community
  • Integrative Oncology and Holistic Care

Beyond the Parade: The Resilience and Legacy of Richard Goldman’s Lifelong Commitment to Community

Rifan Muazin October 7, 2026
Introduction: The Many Facets of Pride Pride is often visually characterized by vibrant parades, colorful floats, and...
Read More Read more about Beyond the Parade: The Resilience and Legacy of Richard Goldman’s Lifelong Commitment to Community
The Art of Intentional Teaching: Why Adding the “Why” Transforms the Yoga Experience the-art-of-intentional-teaching-why-adding-the-why-transforms-the-yoga-experience-1
  • Integrative Oncology and Holistic Care

The Art of Intentional Teaching: Why Adding the “Why” Transforms the Yoga Experience

Evan Lee Salim October 7, 2026
In the modern yoga studio, the air is often filled with a symphony of technical directions. "Lift...
Read More Read more about The Art of Intentional Teaching: Why Adding the “Why” Transforms the Yoga Experience
Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation advancing-the-frontier-of-oncology-taylor-francis-calls-for-submissions-on-biliary-cancer-innovation
  • Clinical Oncology Education

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Neng Nana October 7, 2026
The landscape of hepatobiliary oncology is currently undergoing a period of profound transformation. As researchers decode the...
Read More Read more about Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation
Bridging the Divide: New National Survey Calls for a Unified Standard of Care in Canadian Breast Cancer Treatment bridging-the-divide-new-national-survey-calls-for-a-unified-standard-of-care-in-canadian-breast-cancer-treatment
  • Psychosocial Support and Mental Health

Bridging the Divide: New National Survey Calls for a Unified Standard of Care in Canadian Breast Cancer Treatment

Raul Delapena Setiawan October 7, 2026
Introduction: A Call for Consistency in a Fragmented System Breast cancer, a complex medical challenge comprising over...
Read More Read more about Bridging the Divide: New National Survey Calls for a Unified Standard of Care in Canadian Breast Cancer Treatment
The Medicaid Reckoning: Navigating the $911 Billion Federal Shift the-medicaid-reckoning-navigating-the-911-billion-federal-shift
  • Breast Cancer Legislation and Policy

The Medicaid Reckoning: Navigating the $911 Billion Federal Shift

Ali Ikhwan October 7, 2026
As the United States approaches the 2026 midterm election cycle, state legislatures and gubernatorial administrations are bracing...
Read More Read more about The Medicaid Reckoning: Navigating the $911 Billion Federal Shift

Posts pagination

1 2 3 4 … 702 Next

Recent Posts

  • Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth
  • ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape
  • A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation
  • Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed
  • Pioneering the Future of Medicine: Three Broad Institute Scientists Secure Prestigious NIH High-Risk, High-Reward Grants

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unveiling-a-devious-strategy-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Devious Strategy: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Sagoh October 7, 2026
arrivents-promising-nsclc-candidate-falters-in-phase-iii-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Promising NSCLC Candidate Falters in Phase III Trial, Stock Plummets Amidst Competitive Landscape

Pevita Pearce October 7, 2026
a-new-dawn-for-reproductive-medicine-the-success-of-mitochondrial-donation-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: The Success of Mitochondrial Donation

Rifan Muazin October 7, 2026
unlocking-the-genetic-architecture-of-hearing-loss-a-conversation-with-dr-samah-ahmed
  • Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.